Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01887860 · ClinicalTrials.gov registry record · NA
Patch Test Skin Irritation/Sensitization of Cetaphil Daily Facial Moisturizer SPF 50
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT01887860 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 100 participants.
The verdict
NCT01887860, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Determine if Cetaphil Daily Facial Moisturizer SPF 50 proves to be a contact sensitizer or irritant in certain individuals.
Interventions
- OTHER Cetaphil Daily Facial Moisturizer SPF 50
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01887860
The ClinicalTrials.gov registry entry for NCT01887860 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cetaphil Daily Facial Moisturizer SPF 50 is the first listed.
NCT01887860 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01887860 about?
NCT01887860 is a clinical study titled "Patch Test Skin Irritation/Sensitization of Cetaphil Daily Facial Moisturizer SPF 50". Determine if Cetaphil Daily Facial Moisturizer SPF 50 proves to be a contact sensitizer or irritant in certain individuals.
What is the current status of trial NCT01887860?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2012-12.
What interventions are being tested in trial NCT01887860?
The interventions under investigation include: Cetaphil Daily Facial Moisturizer SPF 50 (OTHER).
Who is sponsoring clinical trial NCT01887860?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.